A mixed formulation of isopsoralen and benzylpropionate for the control of plant bacterial diseases and its preparation method

By using a mixture of isopsoralen and benzylpropionate, a multi-target, multi-pathway mechanism is employed to inhibit bacterial growth and promote plant growth, thus solving the problems of single-agent formulation and easy resistance development in existing technologies. This achieves highly efficient and green control of plant bacterial diseases.

CN123058338APending Publication Date: 2026-11-10SHENYANG TONGXIANG BIOPESTICIDE CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611267574.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-08-20
Publication Date
2026-11-10

AI Technical Summary

Technical Problem

Existing technologies for controlling plant bacterial diseases suffer from problems such as a single mechanism of action of pesticides, easy development of resistance and phytotoxicity, and a lack of green and efficient alternative control strategies.

Method used

To develop a mixed formulation of isopsoralen and benzylpropionate, which inhibits bacterial growth, reproduction and pathogenicity through multiple targets and pathways, and promotes plant growth. The weight ratio of isopsoralen to benzylpropionate in the formulation is 1:20-20:1, and the dosage form includes soluble concentrate, microemulsion or microcapsule formulation.

Benefits of technology

It significantly improved the control of various bacterial plant diseases, such as bacterial angular leaf spot of cucumber, bacterial canker of citrus and bacterial stripe of rice, reduced the cost of pesticide use, reduced the number of applications, and enhanced the plant's disease resistance and growth promotion effect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
  • Figure FT_3
    Figure FT_3
Patent Text Reader

Abstract

This invention provides a mixed formulation of isopsoralen and benzo[a]pyrethrum for the control of plant bacterial diseases and its preparation method. The formulation comprises isopsoralen, benzo[a]pyrethrum, and excipients. The active ingredients of the mixed formulation are isopsoralen and benzo[a]pyrethrum, with a weight ratio of isopsoralen to benzo[a]pyrethrum of 1:20-20:1. This invention possesses triple functions of bactericidal action, growth promotion, and disease resistance induction, exhibiting a significant synergistic effect. On one hand, it effectively inhibits bacterial growth, reproduction, and pathogenicity through multi-target and multi-pathway mechanisms, such as interfering with pathogenic bacteria's perception of environmental signals, affecting their energy and material metabolism, and weakening their virulence system. On the other hand, it enhances disease resistance by promoting plant growth. Therefore, this formulation demonstrates excellent control capabilities against various plant bacterial diseases, including bacterial angular leaf spot of cucumber, citrus canker, and bacterial stripe of rice.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of pesticide technology, and in particular to a mixed formulation of isopsoralen and benzylpropionate for the control of plant bacterial diseases and its preparation method. Background Technology

[0002] Bacterial diseases of crops are becoming increasingly prevalent both domestically and internationally. It is estimated that there are 650-700 species of bacterial plant diseases worldwide, with 150-200 species recorded in China, accounting for approximately one-quarter to one-third of the world's total. Although bacterial plant diseases constitute a relatively small proportion of all plant diseases, their harmfulness is extremely serious, and their control is very difficult.

[0003] Currently, the main methods for controlling bacterial diseases in China rely on antibiotics and copper-based pesticides. The variety of available pesticides is far less than that for fungal diseases. Antibiotics and copper-based pesticides are growth inhibitors, acting by suppressing the basal growth and metabolism of pathogens. Practice has shown that due to their singular mechanism of action, long-term and excessive use easily leads to bacterial resistance, rendering the pesticides ineffective. Furthermore, the use of inorganic copper can cause phytotoxicity and attract spider mites, which can then damage crops. Therefore, developing green and efficient alternative control strategies is imperative.

[0004] Currently, biological control of bacterial diseases in China mainly focuses on three directions: biocontrol bacteria, plant-derived fungicides, and plant immune inducers. Plant-derived fungicides utilize antibacterial components in natural plant extracts to directly inhibit or kill pathogens. Plant immune inducers can activate the plant's own immune system by regulating multiple pathways, modulating the expression of defense-related genes, and strengthening the plant's biochemical defense capabilities, thereby effectively improving the plant's ability to resist diseases and its resilience to adverse environments. Compared with chemical pesticides, biological control has advantages such as being environmentally friendly and less likely to induce resistance, and has become an important direction for the green control of this disease. Summary of the Invention

[0005] To address the shortcomings mentioned above, this invention provides a mixed formulation of isopsoralen and benzylpropionate for the control of plant bacterial diseases. This formulation possesses triple functions of fungicide, growth promoter, and disease resistance, exhibiting a significant synergistic effect. On one hand, it effectively inhibits bacterial growth, reproduction, and pathogenicity through multiple targets and pathways, including interfering with pathogenic bacteria's perception of environmental signals, affecting their energy and metabolism, and weakening their virulence systems. On the other hand, it enhances disease resistance by promoting plant growth. Therefore, this formulation demonstrates excellent control capabilities against various plant bacterial diseases, such as bacterial angular leaf spot of cucumber, citrus canker, and bacterial stripe of rice.

[0006] To address the aforementioned problems, this invention provides a mixed formulation of isopsoralen and benzo[a]pyrethrum for the control of plant bacterial diseases. The mixed formulation comprises isopsoralen, benzo[a]pyrethrum, and excipients. The active ingredients of the mixed formulation are isopsoralen and benzo[a]pyrethrum, and the weight ratio of isopsoralen to benzo[a]pyrethrum is 1:20-20:1.

[0007] Preferably, in the mixed formulation for controlling plant bacterial diseases, the weight ratio of isopsoralen to benzo[a]pyrethrum is 1:2.

[0008] Preferably, the mixed formulation for preventing and controlling plant bacterial diseases is a soluble concentrate, microemulsion, or microcapsule formulation.

[0009] A method for preparing a mixed formulation of isopsoralen and benzo[i]pyrethrum for the control of plant bacterial diseases, comprising the following steps: mixing isopsoralen and benzo[i]pyrethrum in a weight ratio of 1:20-20:1, adding appropriate excipients, and homogenizing the mixture to prepare a target formulation for the control of plant bacterial diseases.

[0010] Preferably, the target dosage form is a soluble concentrate, and the excipients are prepared from the following raw materials in weight percentage: 1% benzo[a]pyrrolidone, 2% isopsoralen, 30% propylene glycol, 1% N-methylpyrrolidone, 1% alkyl glycoside O814, 7% Tween-80, 10% styrene-phenol polyoxyethylene polyoxypropylene ether, and 48% deionized water. First, isopsoralen and benzo[a]pyrrolidone are dissolved in N-methylpyrrolidone, and then propylene glycol, alkyl glycoside, Tween-80, and styrene-phenol polyoxyethylene polyoxypropylene ether are added sequentially. After stirring evenly, deionized water is added while stirring until a homogeneous liquid is formed, thus obtaining the soluble concentrate.

[0011] Preferably, the target dosage form is a microemulsion, and the excipients are prepared from raw materials comprising the following weight percentages: 0.2% benzo[a]pyrethrin, 0.1% isopsoralen, 13% castor oil polyoxyethylene ether, 1% calcium dodecylbenzenesulfonate, 35% glycerol, 2% polyethylene glycol, and 48.7% deionized water. First, isopsoralen and benzo[a]pyrethrin are dissolved in glycerol to obtain an oil phase. Then, castor oil polyoxyethylene ether, calcium dodecylbenzenesulfonate, polyethylene glycol, and deionized water are mixed and stirred evenly to obtain an aqueous phase. The aqueous phase is then slowly added to the oil phase while stirring, and finally stirred until a homogeneous and transparent liquid is obtained, which is the microemulsion.

[0012] Preferably, the target dosage form is a microcapsule formulation, and the excipients are prepared from raw materials comprising the following weight percentages: 6% benzo[a]pyrethrum, 1.5% isopsoralen, 9% isocyanate, 5% Span-80, 6% fatty alcohol polyoxyethylene ether, 9% sodium lignosulfonate, 1.5% ethylenediamine, 2% ethylene glycol, and 60% deionized water. First, isopsoralen and benzo[a]pyrethrum are fully dissolved in the isocyanate monomer, then Span-80 is added and stirred until homogeneous to prepare the oil phase. Separately, deionized water is taken, and fatty alcohol polyoxyethylene ether, sodium lignosulfonate, and ethylene glycol are added sequentially, stirring continuously until completely dissolved and homogeneous. The pH of the system is adjusted to 7-8 to obtain the aqueous phase. Under high-speed stirring, the oil phase is slowly added dropwise to the aqueous phase, while simultaneously adding an aqueous solution of ethylenediamine dropwise, to obtain the isopsoralen•benzo[a]pyrethrum microcapsule formulation.

[0013] Preferably, under stirring conditions, the oil phase is slowly added dropwise to the aqueous phase, followed by high-speed shear emulsification at 10,000 rpm for 20 min to prepare a stable O / W emulsion. Then, under stirring conditions, an aqueous solution of ethylenediamine is slowly added dropwise to the above O / W emulsion. After stirring at a constant temperature for 50 min, a small amount of impurities is removed by filtration to obtain the isopsoralen-benzylpropionate microcapsule formulation.

[0014] Preferably, the isopsoralen is prepared by the following steps:

[0015] S10. First, mix choline chloride and ethylene glycol in a 1:2 molar ratio and stir at 60°C until a homogeneous and transparent liquid is formed to obtain a eutectic solvent system.

[0016] S20. After crushing the Psoralea corylifolia seeds to 60 mesh using a high-speed seed crusher, add a DES-ethanol mixture with a volume ratio of 7:3, wherein the material-to-liquid ratio is 1:20 g / mL.

[0017] S30. After ultrasonic-assisted extraction, centrifugation, and filtration of the supernatant, the above solution is extracted with 3 times the volume of ethyl acetate. The ethyl acetate layer is collected and concentrated under reduced pressure to obtain the extract.

[0018] S40. Dissolve the above extract in methanol at a mass-volume ratio of 1:25 g / mL, and analyze the components of the extract using analytical high performance liquid chromatography to confirm the retention time of isopsoralen.

[0019] S50. Use a semi-preparative high-performance liquid chromatograph to separate and purify the components in the extract;

[0020] S60. The isopsoralen fraction was manually collected according to the retention time window determined by the analytical chromatogram. The collected liquids were combined and concentrated under reduced pressure at 40°C to remove the solvent, so as to obtain pure isopsoralen.

[0021] Compared with the prior art, the present invention has the following advantages:

[0022] 1. In this invention, when isopsoralen and benzpromide are combined in a certain proportion, they can simultaneously exert a triple effect of fungicide, plant growth promotion and induction of plant disease resistance, and produce a significant synergistic effect. When benzpromide is used alone, the control efficacy against bacterial angular leaf spot of cucumber is 51.00%, when isopsoralen is used alone, it is 73.73%, and when the two are mixed at a weight ratio of 1:2, the control efficacy is as high as 91.04%, which is significantly better than single agents and control agents.

[0023] 2. In this invention, when isopsoralen and benzyl benzoate are combined in a certain proportion, they can not only inhibit the growth, reproduction and pathogenicity of bacteria through multiple targets and pathways, such as destroying the bacterial cell membrane structure, interfering with energy metabolism and inhibiting the virulence system, but also promote plant growth and improve disease resistance by increasing the chlorophyll content in the plant. This multi-target and multi-pathway mechanism makes it difficult for pathogens to develop drug resistance through single gene mutation.

[0024] 3. In this invention, the two active ingredients are mixed to not only enhance each other's effects, but also because both are natural products that are easily degraded from nature. This solves the problems of food safety, threats to human health, and environmental pollution caused by artificially synthesized chemical pesticide residues.

[0025] 4. This invention not only has a significant synergistic effect, but also has two uses: it is both a fungicide for treating and preventing diseases and a plant growth regulator for promoting photosynthesis and increasing yield. This not only reduces the cost of pesticides, but also reduces the number of applications, saving manpower, material resources and financial resources, and increasing farmers' income.

[0026] 5. In this invention, benzo[a]pyrethrum is a plant-derived fungicide that can increase chlorophyll content and ribulose-1,5-bisphosphate carboxylase activity in the photosynthetic system, as well as significantly enhance the activity of antioxidant enzymes, thereby promoting plant growth and improving plant disease resistance. At the same time, isopsoralen, with its two-component system as the core signal hub, downregulates the expression of key genes in multiple pathways such as downstream bacterial chemotaxis, flagella assembly, and bacterial secretion system through multi-pathway and multi-target synergistic regulation, thereby disrupting the integrity of bacterial cell structure, inhibiting its motility and biofilm formation, and ultimately achieving effective inhibition of bacterial growth and reproduction and its pathogenicity to host plants. Attached Figure Description

[0027] Figure 1 This is a bar chart of the differentially expressed genes in this invention;

[0028] Figure 2 This is a schematic diagram of bacterial phosphonic acid and phosphonate metabolism according to the present invention;

[0029] Figure 3This is a pathway diagram of bacterial chemotactic interactions between the Y and CK groups of the present invention;

[0030] Figure 4 This is a pathway diagram of the interaction between the Y and CK groups in a two-component system according to the present invention;

[0031] Figure 5 This is a pathway diagram of the interaction between the Y and CK groups in the bacterial secretion system according to the present invention;

[0032] Figure 6 This is a structural diagram of the flagella assembly pathway of the present invention. Detailed Implementation

[0033] To make the objectives, technical solutions, and advantages of the present invention clearer, the present invention will be further described in detail below with reference to the accompanying drawings and embodiments, but the embodiments are not intended to limit the present invention.

[0034] In this embodiment, the molecular mechanism by which isopsoralen kills bacterial angular leaf spot pathogens of cucumber lies in its multi-target and multi-pathway mechanism, which effectively inhibits the growth, reproduction and pathogenicity of bacteria by interfering with the pathogen's perception of environmental signals, affecting its energy and material metabolism, and weakening its virulence system.

[0035] Example 1: Preparation of isopsoralen

[0036] First, choline chloride (ChCl) and ethylene glycol are mixed at a molar ratio of 1:2 and stirred at 60°C until a homogeneous and transparent liquid is formed, thus obtaining a deep eutectic solvent (DES) system.

[0037] Weigh 100g of Psoralea corylifolia seeds and grind them to about 60 mesh using a high-speed seed grinder. Add DES-ethanol mixture (volume ratio 7:3) and a material-liquid ratio of 1:20 (g / mL). Extract with ultrasonic assistance (frequency 40 kHz, power 300 W, 40°C, 30 min). Centrifuge (5000 rpm, 10 min). Filter the supernatant and extract with 3 times the volume of ethyl acetate. Collect the ethyl acetate layer and concentrate under reduced pressure to obtain about 5g of extract.

[0038] The above extract was dissolved in methanol at a mass-to-volume ratio of 1:25 (g / mL). The components of the extract were analyzed using an analytical high-performance liquid chromatograph (HPLC). The chromatographic column was C18 (250×4.6 mm, 5 μm), the mobile phase was methanol:water = 65:35 (v / v), the flow rate was 1.0 mL / min, the detection wavelength was 254 nm, and the column temperature was 30 °C. The retention time of isopsoralen was confirmed.

[0039] The components in the extract were separated and purified using a semi-preparative high-performance liquid chromatography (HPLC) system. The chromatographic column was C18 (250×10 mm, 5 μm), the mobile phase was methanol:water = 65:35 (v / v), the flow rate was 5 mL / min, the detection wavelength was 254 nm, and the single sample loading volume was 10 mg. The isopsoralen fraction was manually collected according to the retention time window determined by the analytical chromatogram. The collected liquids were combined and concentrated under reduced pressure at 40 °C to remove the solvent, yielding pure isopsoralen (purity ≥98%).

[0040] Example 2: The bactericidal mechanism of isopsoralen against bacterial angular leaf spot of cucumber

[0041] Single colonies of *Cucumber angular leaf spot*, uniform in size and concentrically shaped with a dirty white color, were selected and inoculated onto NB solid medium using the streak plating method. The culture was continuously purified for 3–4 generations in a 28°C incubator, with each generation incubated for 2 days. Purified single colonies were picked and inoculated into 50 mL of NB liquid medium, and cultured with shaking at 28°C and 180 r / min until the logarithmic growth phase. Subsequently, the inoculum was transferred to 25 mL of fresh NB liquid medium at a 1% (v / v) inoculation rate and cultured until the bacterial OD reached the target growth rate. 600 When the value reaches 0.6, a suspension of the test bacteria in the logarithmic growth phase is obtained.

[0042] 0.5 mL of the above bacterial suspension was added to the isopsoralen treatment group (Y) and the control group (CK), with 3 biological replicates for each group. The treatment group was given isopsoralen stock solution to achieve a final concentration of 100 mg·L⁻¹. -1 The control group was treated with an equal volume of sterile water as a blank control. The treated bacterial suspension was cultured in a shaker at 28℃ and 180 r / min for 4 h. After the culture was completed, it was centrifuged at 1515×g and 4℃ for 10 min. The supernatant culture medium was discarded, the bacterial pellet was collected, and the bacterial pellet was immediately frozen in liquid nitrogen for 30 min. Then it was transferred to an ultra-low temperature freezer at -80℃ for storage and used for RNA extraction.

[0043] After extracting the total amount of RNA from the above samples, the purity and concentration of RNA were detected using a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific, USA), the integrity of the RNA samples was assessed by agarose gel electrophoresis (Biowest, ES), and the RQN value was determined by an Agilent 5300 (Agilent, USA). Subsequently, the sequencing experiment used the Illumina® Stranded mRNA Prep, Ligation (constant) method to construct the library.

[0044] The constructed library was sequenced using a second-generation high-throughput sequencing platform, yielding 150 bp paired-end reads. The raw sequencing data was in FASTQ format. Quality control was performed using FASTP software, filtering out low-quality sequences to obtain high-quality clean reads. Gene and transcript expression levels were then quantified using RSEM with TPM as the indicator. Based on the quantitative results, DESeq2 was used to identify differentially expressed genes (DEGs).

[0045] Reference genome version: GCF_030252675.1

[0046] Reference genome source:

[0047] https: / / www.ncbi.nlm.nih.gov / datasets / genome / GCF_030252675.1 / .

[0048] The DESeq package in R was used for analysis. Genes with p-value < 0.05 and FC ≥ 2 were considered significantly upregulated genes, and genes with p-value < 0.05 and FC ≤ 0.5 were considered significantly downregulated genes. These genes were compared to the COG, GO, and KEGG databases. KEGG enrichment analysis was performed on the differentially regulated genes, and pathways with p-value < 0.05 were considered significantly enriched pathways.

[0049] The molecular mechanism of isopsoralen's bactericidal activity was obtained based on analysis of significantly enriched metabolic pathways.

[0050] like Figure 1 As shown, isopsoralen treatment (100 mg·L⁻¹) -1 After 4 h, the treatment group (Y) and the blank control group (CK) produced a total of 136 differentially expressed genes (DEGs), of which 40 were upregulated and 96 were downregulated.

[0051] KEGG enrichment analysis showed that differentially expressed genes (DEGs) were mainly enriched in 14 significant pathways, including phosphonic acid and phosphonate metabolism, bacterial chemotaxis, two-component systems, bacterial secretion systems, flagella assembly, and extracellular polysaccharide biosynthesis, focusing on three major levels: energy and material metabolism, cell structural integrity, and regulation of bacterial motility and virulence.

[0052] (1) Analysis of phosphonic acid and phosphonate metabolic pathways

[0053] like Figure 2As shown, under the action of isopsoralen, the transcriptional level of CP lyase system proteins involved in methylphosphonate metabolism is significantly reduced. Therefore, pathogens cannot utilize phosphorus sources through phosphonate metabolism under stress. Simultaneously, the pentose phosphate pathway is blocked, resulting in a lack of nucleotide and nucleic acid precursors, affecting rapid cell proliferation. Furthermore, the lack of reducing power provided by NADPH affects cellular synthesis and antioxidant capacity. Thus, the growth and reproduction of pathogens are inhibited, achieving the purpose of sterilization.

[0054] Figure 2 In the diagram, the first three cells represent the isopsoralen treatment group (Y), and the last three cells represent the control group (CK); blue indicates downregulated expression levels, and red indicates upregulated expression levels.

[0055] Table 1. Statistical table of differentially expressed genes in the phosphonate and phosphonate metabolic pathways between the Y and CK groups.

[0056]

[0057] Note: FC represents the fold difference of the gene between the two samples, and p-value < 0.05 indicates a significant difference.

[0058] (2) Bacterial chemotaxis pathway

[0059] like Figure 3 As shown, under the action of isopsoralen, the downregulation of the expression of bacterial chemotactic signal initiation receptors MCP and Aer prevents pathogens from effectively recognizing chemotactic signals in the environment, such as host colonization signals or harmful substances, thus losing their ability to infect the host and resist adversity; at the same time, the downregulation of CheV expression causes it to lose its ability to regulate this pathway.

[0060] Figure 3 In the diagram, the first three cells represent the isopsoralen treatment group (Y), and the last three cells represent the control group (CK); blue indicates downregulated expression levels, and red indicates upregulated expression levels.

[0061] Table 2. Gene statistics of changes in bacterial chemotaxis pathway in groups Y and CK.

[0062]

[0063] Note: FC represents the fold difference of the gene between the two samples, and p-value < 0.05 indicates a significant difference.

[0064] (3) Bacterial two-component system

[0065] like Figure 4As shown, the two-component signal transduction system (TCSTS) is a core pathway for bacteria to achieve environmental adaptation and physiological regulation. Eighteen DEGs were enriched in this system, all of which were significantly downregulated. This indicates that under the action of isopsoralen, multiple pathways in the two-component system involved in sensing environmental signals and regulating physiological responses are significantly reduced. The growth, colonization, energy and material supply, cell structural stability, infection and spread capabilities, and pathogenicity of the pathogen are significantly inhibited, thereby achieving the effect of preventing and controlling bacterial angular leaf spot in cucumber.

[0066] Figure 4 In the diagram, the first three cells represent the isopsoralen treatment group (Y), and the last three cells represent the control group (CK); blue indicates downregulated expression levels, and red indicates upregulated expression levels.

[0067] Table 3. Statistical table of differentially expressed genes between Y and CK groups in the two-component system pathway.

[0068]

[0069] Note: FC represents the fold difference of the gene between the two samples, and p-value < 0.05 indicates a significant difference.

[0070] (4) Bacterial secretion system

[0071] like Figure 5 As shown, isopsoralen downregulates the expression of key genes in the type III secretion system (T3SS) and type II secretion system (T2SS) of pathogenic bacteria, thereby blocking the secretion of their effector proteins and toxins and weakening their pathogenicity. Simultaneously, under isopsoralen stress, a compensatory stress response is initiated to maintain the pathogen's survival and adaptability.

[0072] Figure 5 In the diagram, the first three cells represent the isopsoralen treatment group (Y), and the last three cells represent the control group (CK); blue indicates downregulated expression levels, and red indicates upregulated expression levels.

[0073] Table 4. Statistical table of differentially expressed genes in the bacterial secretion system pathway between the Y and CK groups.

[0074]

[0075] Note: FC represents the fold difference of the gene between the two samples, and p-value < 0.05 indicates a significant difference.

[0076] (5) Flagella assembly pathway

[0077] like Figure 6As shown, under the action of isopsoralen, the power supply for flagellar movement is blocked by inhibiting the dynein MotY, while the expression of flagellar filament proteins FliT, FliS and FliC is reduced, thereby weakening the flagellar assembly efficiency and destroying the structural integrity of the flagellar filaments. This leads to a decrease in the motility, chemotaxis and infection ability of pathogens, thus achieving a bactericidal effect.

[0078] Figure 6 In the diagram, the first three cells represent the isopsoralen treatment group (Y), and the last three cells represent the control group (CK); blue indicates downregulated expression levels, and red indicates upregulated expression levels.

[0079] Table 5. Statistical table of differentially expressed genes in the flagellar assembly pathway between the Y and CK groups.

[0080]

[0081] Note: FC represents the fold difference of the gene between the two samples, and p-value < 0.05 indicates a significant difference.

[0082] Example 3: Preparation of soluble solvent

[0083] The excipients are prepared from the following raw materials in the following weight percentages: 1% phenylpropenol, 2% isopsoralen, 30% propylene glycol, 1% N-methylpyrrolidone, 1% alkyl glycoside O814, 7% Tween-80, 10% styrene-phenol polyoxyethylene polyoxypropylene ether, and 48% deionized water.

[0084] The preparation steps are as follows: First, dissolve isopsoralen and benzoylpyrrolidone in N-methylpyrrolidone. Then, add propylene glycol, alkyl glycoside, Tween-80 and tristyrene-phenol polyoxyethylene polyoxypropylene ether in sequence. After stirring evenly, add deionized water while stirring until a homogeneous liquid is formed, and the soluble solvent can be obtained.

[0085] Example 4: Formulation of microemulsions

[0086] The excipients are prepared from raw materials comprising the following percentages by weight: 0.2% benzoyl propionate, 0.1% isopsoralen, 13% castor oil polyoxyethylene ether, 1% calcium dodecylbenzenesulfonate, 35% glycerol, 2% polyethylene glycol, and 48.7% deionized water.

[0087] Preparation process: First, isopsoralen and benzoyl propionate are dissolved in glycerol to obtain an oil phase. Then, castor oil polyoxyethylene ether, calcium dodecylbenzene sulfonate, polyethylene glycol and deionized water are mixed and stirred evenly to obtain an aqueous phase. The aqueous phase is then slowly added to the oil phase while stirring. Finally, the mixture is stirred until a homogeneous and transparent liquid is obtained, which is the microemulsion.

[0088] Example 5: Formulation of microcapsule formulation

[0089] The excipients are prepared from raw materials comprising the following percentages by weight: 6% benzoyl ether, 1.5% isopsoralen, 9% isocyanate, 5% Span-80, 6% fatty alcohol polyoxyethylene ether, 9% sodium lignosulfonate, 1.5% ethylenediamine, 2% ethylene glycol, and 60% deionized water.

[0090] Preparation process: First, isopsoralen and benzo[i]propiconazole are fully dissolved in isocyanate monomers, then Span-80 is added and stirred until homogeneous to prepare the oil phase; separately, deionized water is taken, and fatty alcohol polyoxyethylene ether, sodium lignosulfonate, and ethylene glycol are added sequentially, and stirred continuously until completely dissolved and homogeneous. The pH of the system is adjusted to 7-8 to obtain the aqueous phase; under stirring conditions, the oil phase is slowly added dropwise to the aqueous phase, followed by high-speed shear emulsification at 10000 rpm for 20 min to prepare a stable O / W type emulsion; stirring is continued, and ethylenediamine aqueous solution is slowly added dropwise, and the reaction is carried out at a constant temperature and stirred for 50 min to form a polyurea capsule wall through interfacial polymerization, encapsulating the active components; after the reaction is completed, a small amount of impurities are removed by filtration, and finally the isopsoralen·benzo[i]propiconazole microcapsule formulation is obtained.

[0091] Example 6: Inhibition rate of different ratios of isopsoralen and benzylpyridin combination and its single agent against cucumber bacterial angular leaf spot pathogen

[0092] The combined virulence of isopsoralen and benomyl against *Cucumber angular leaf spot* was determined using a liquid culture method. Five treatment groups were established: isopsoralen:benzyl (2:1), isopsoralen:benzyl (1:2), isopsoralen:benzyl (1:4), and isopsoralen and benomyl alone. The inhibition rate against *Cucumber angular leaf spot* was measured. 1 mL of logarithmic growth phase bacterial suspension and 0.5 mL of the test agent stock solution were added to 48.5 mL of LB liquid medium to achieve a final concentration of 200 mg·L⁻¹. -1 An equal volume of sterile water was added as a blank control, and each treatment was repeated three times. The temperature was 28℃ and the rotation speed was 180 r·min. -1 Under shaking conditions, the OD of the bacterial culture in the blank control group was measured. 600 The value was around 0.3, and the OD values ​​for each treatment were measured. 600 The inhibition rate of different agents on the tested bacteria is calculated using the following formula:

[0093] Inhibition rate = (A0-A1) / A0×100% Formula 1

[0094] In the formula: A0—OD of the blank control group before and after culture 600 Increased value; A1—OD before and after culture in the drug-treated group 600 Increased value.

[0095] Table 6. Inhibition rates of different ratios of isopsoralen and benzylpyridin, and their individual agents, against *Cucumber angular leaf spot*.

[0096]

[0097] Note: Different lowercase letters in the same column indicate significant differences (P < 0.05), and all OD values ​​are net increases after deducting 0h.

[0098] It can be seen that at 200 mg·L -1 At the specified concentrations, the inhibition rates of isopsoralen:benzylpropionol (2:1), isopsoralen:benzylpropionol (1:2), and isopsoralen:benzylpropionol (1:4) against bacterial angular leaf spot of cucumber were 90.789%, 98.684%, and 85.526%, respectively, which were much higher than the antibacterial activity of either agent alone.

[0099] Example 7: Growth-promoting effect on tobacco

[0100] Healthy, uniformly growing common tobacco plants at the 6-8 leaf stage were selected. A blank control (CK) was set up. Seven treatments were applied: a 3500-fold diluted control agent, Bihu (a wettable powder of indomethacin for brassinolide), and 2000-fold diluted formulations from Examples 3, 4, and 5, as well as 0.2% benzylpropargyl soluble liquid and 0.1% isopsoralen soluble liquid. Treatments were applied three times, with a 5-day interval between each application. Samples were taken 7 days after the third application. Each treatment was replicated three times, with 18 plants per replicate. The stem diameter (mm), plant height (mm), aboveground fresh weight (g), and underground fresh weight (g) of the newly formed tissues were measured. The tobacco plants were dried in an 80℃ constant temperature drying oven to constant weight, and the aboveground and underground dry weights were measured. The growth rate and weight gain rate were calculated using the following formula. Stem diameter growth rate (%) = ×100 Formula 2-1 Plant height growth rate (%) = ×100 Formula 2-2 Dry weight growth rate (%) = ×100 Formula 2-3 Fresh weight growth rate (%) = ×100 Formula 2-4

[0101] Table 7 Effects of different agents on tobacco stem diameter and plant height

[0102]

[0103] Note: Different lowercase letters in each column indicate significant differences between treatments (P < 0.05).

[0104] Table 8. Effects of different agents on the weight of tobacco aboveground parts

[0105]

[0106] Note: Different lowercase letters in each column indicate significant differences between treatments (P < 0.05).

[0107] Table 9. Effects of different agents on the weight of the underground parts of tobacco.

[0108]

[0109] Note: Different lowercase letters in each column indicate significant differences between treatments (P < 0.05).

[0110] It can be seen that the growth-promoting effects of the 2000-fold dilutions of Example 3 (isopsoralen: benzylpropionol = 2:1), Example 4 (isopsoralen: benzylpropionol = 1:2), and Example 5 (isopsoralen: benzylpropionol = 1:4) on tobacco stem diameter were 22.00%, 33.00%, and 28.00%, respectively; plant height was 47.03%, 54.07%, and 49.94%, respectively; above-ground fresh weight was 41.22%, 51.25%, and 48.33%, respectively; above-ground dry weight was 70.02%, 78.29%, and 72.98%, respectively; underground fresh weight was 137.20%, 161.22%, and 145.49%, respectively; and underground dry weight was 115.09%, 151.89%, and 132.08%, respectively. All indicators were significantly higher than the growth-promoting effects of the single agents and the control agent, with the isoporalen: benzylpropionol (1:2) showing the best results.

[0111] Example 8: Control effect on bacterial angular leaf spot of cucumber

[0112] After removing the growing point from 2–3 leaf stage, Xinjin Chun No. 4 cucumber seedlings with uniform growth were selected, and sprayed with a micro-sprayer after diluting the microemulsions of Examples 3, 4, and 5, 0.2% benzyl propiconazole microemulsion, and 0.1% isopsoralen microemulsion with distilled water 375 times. Alternatively, a 1000-fold dilution of 33.5% quinoline copper suspension (with an effective ingredient concentration of approximately 335 mg·L⁻¹) was used. -1 ), 3% Kasugamycin powder diluted 333 times (active ingredient concentration approximately 100 mg·L⁻¹) -1 The control group consisted of 1000 microorganisms (approximately 1000 μL) and an equal volume of distilled water as a blank control. Each treatment was replicated three times, with nine strains per replicate. After 24 hours, the bacterial suspension (approximately 1 × 10⁻⁶) was... 7 CFU·mL -1 Spray evenly onto the second true leaf of the plant until it is covered with droplets but not converging. The inoculation amount per plant is about 1 mL.

[0113] Immediately after inoculation, the cucumbers were placed in an artificial climate chamber (28℃, relative humidity ≥95%, 12 h light / 12 h dark) to induce disease. After 3 days, they were moved to a greenhouse (25±2℃, relative humidity 70–80%, 16 h light / 8 h dark) for continued cultivation. When the blank control showed sufficient disease, the disease severity on the second true leaf of the cucumber was investigated according to the People's Republic of China Agricultural Industry Standard NY / T1857.6—2010. The disease index and control efficacy were calculated using the formula below.

[0114] Table 10 Grading Table for Cucumber Bacterial Angular Leaf Spot Disease

[0115]

[0116] Disease index (%) = ×100 formula

[0117] Prevention and control effect (%) = ×100 formula

[0118] Table 11. Effects of different agents on the prevention and treatment of bacterial angular leaf spot in cucumber.

[0119]

[0120] Note: Different lowercase letters in each column indicate significant differences between treatments (P < 0.05).

[0121] It can be seen that the control effects of Example 3 (isopsoralen: benzylpropionate = 2:1), Example 4 (isopsoralen: benzylpropionate = 1:2), and Example 5 (isopsoralen: benzylpropionate = 1:4) diluted 2000 times on bacterial angular leaf spot of cucumber were 88.06%, 91.04%, and 83.47%, respectively. These were all significantly higher than the control effects of the two single agents and the mainstream varieties on the market. Moreover, the isoporalen: benzylpropionate (1:2) was the most effective.

[0122] Example 9: Field efficacy trial of a pesticide for controlling citrus canker.

[0123] The experimental crop, Newhall, was 6 years old, with a plant spacing of 4×4 m. The trees were of medium vigor, and the overall fertilizer and water management in the orchard was above average. The soil fertility was moderate. No fungicide was sprayed for the first 3 months of this experiment. Other cultivation and management were the same as in ordinary production orchards. Citrus canker disease had been a serious problem in this orchard in previous years, with obvious symptoms of leaf and fruit canker, causing leaf and fruit drop and a decline in fruit quality.

[0124] The experiment included the following formulations: Examples 3, 4, and 5; 0.2% benzylpropargyl microemulsion and 0.1% isopsoralen microemulsion, each diluted 1500 times before spraying. Controls were provided by a 1000-fold dilution of 33.5% quinoline copper suspension and a 600-fold dilution of 4% kasugamycin wettable powder. An equal volume of water served as a blank control. Three plants were planted per plot, with four replicates. Application began during the fruit enlargement stage, with three sprays applied at nine-day intervals. Leaf and fruit canker symptoms were assessed 15 days after the third application.

[0125] According to Part 103 of the national standard "Field Efficacy Test Guidelines for Pesticides (II)": Control of Citrus Canker with Fungicides (GB / T17980.103-2004), the occurrence of citrus canker was investigated by grade. Two trees were investigated in each plot, and five points were taken from each tree according to the directions of east, west, south, north and center. At each point, all leaves on two shoots and 10 fruits were investigated, and the disease status was recorded by grade.

[0126] The grading standards for leaves (fruits) are as follows:

[0127] Grade 0: No disease; Grade 1: 1-5 lesions per leaf (fruit); Grade 3: 6-10 lesions per leaf (fruit); Grade 5: 11-15 lesions per leaf (fruit); Grade 7: 16-20 lesions per leaf (fruit); Grade 9: 21 or more lesions per leaf (fruit).

[0128] Disease index = Σ(number of diseased leaves (fruits) at each level × relative level value) / (total number of leaves (fruits) surveyed × 9) × 100

[0129] Prevention and control efficacy (%) = (Disease index in blank control area - Disease index in treatment area) / Disease index in blank control area × 100

[0130] Table 12 Results of experiments on the control of citrus canker with different agents

[0131]

[0132] The results showed that the control efficacy of the tested agents Example 3 (isopsoralen: benomyl = 2:1), Example 4 (isopsoralen: benomyl = 1:2), and Example 5 (isopsoralen: benomyl = 1:4) at a dilution of 1500 times against citrus canker was 87.35%, 90.04%, and 85.26%, respectively, which were higher than those of 0.5% benomyl and 0.1% isoporalen microemulsion single agents and control agents. Moreover, the isoporalen: benomyl (1:2) ratio showed the best effect.

[0133] Although embodiments of the present invention have been shown and described above, it is understood that the above embodiments are exemplary and should not be construed as limiting the present invention. Those skilled in the art can make changes, modifications, substitutions and variations to the above embodiments within the scope of the present invention.

[0134] Furthermore, the terms "first" and "second" are used for descriptive purposes only and should not be construed as indicating or implying relative importance or implicitly specifying the number of indicated technical features. Thus, a feature defined as "first" or "second" may explicitly or implicitly include at least one of that feature. In the description of this patent application, "a plurality of" means at least two, such as two, three, etc., unless otherwise explicitly specified.

[0135] In this specification, unless otherwise expressly specified and limited, "above" or "below" the second feature can mean that the first and second features are in direct contact, or that the first and second features are in indirect contact through an intermediate medium. Furthermore, "above," "over," and "on top" of the second feature can mean that the first feature is directly above or diagonally above the second feature, or simply that the first feature is at a higher horizontal level than the second feature. "Below," "below," and "under" the second feature can mean that the first feature is directly below or diagonally below the second feature, or simply that the first feature is at a lower horizontal level than the second feature.

[0136] In the description of this specification, the references to terms such as "one embodiment," "some embodiments," "example," "specific example," or "some examples," etc., indicate that a specific feature, structure, material, or characteristic described in connection with that embodiment or example is included in at least one embodiment or example of the present invention. In this specification, the illustrative expressions of the above terms do not necessarily refer to the same embodiment or example. Furthermore, the specific features, structures, materials, or characteristics described may be combined in any suitable manner in one or more embodiments or examples. Moreover, without contradiction, those skilled in the art can combine and integrate the different embodiments or examples described in this specification, as well as the features of different embodiments or examples.

[0137] Although embodiments of the present invention have been shown and described above, it is understood that the above embodiments are exemplary and should not be construed as limiting the present invention. Those skilled in the art can make changes, modifications, substitutions and variations to the above embodiments within the scope of the present invention.

Claims

1. A mixed formulation of isopsoralen and benzylpropionate for the control of plant bacterial diseases, characterized in that, The mixed formulation for controlling plant bacterial diseases consists of isopsoralen, benzylpropionate, and excipients. The active ingredients of the mixed formulation for controlling plant bacterial diseases are isopsoralen and benzylpropionate, and the weight ratio of isopsoralen to benzylpropionate is 1:20-20:

1.

2. The mixed formulation of isopsoralen and benzylpropionate for controlling plant bacterial diseases as described in claim 1, characterized in that, In the aforementioned mixed formulation for controlling plant bacterial diseases, the weight ratio of isopsoralen to benzyl propiconazole is 1:

2.

3. A mixed formulation of isopsoralen and benzylpropionate for controlling plant bacterial diseases as described in claim 1 or 2, characterized in that, The mixed preparation for preventing and treating plant bacterial diseases is a soluble concentrate, microemulsion, or microcapsule preparation.

4. A method for preparing a mixed formulation of isopsoralen and benzyl propiconazole for controlling plant bacterial diseases, characterized in that, Includes the following steps: Isopsoralen and benzyl propiconazole are mixed in a weight ratio of 1:20-20:1, and appropriate excipients are added. After homogenization, a mixed formulation for the control of plant bacterial diseases in the target formulation is prepared.

5. The preparation method of the mixed formulation of isopsoralen and benzyl propiconazole for controlling plant bacterial diseases as described in claim 4, characterized in that, The target dosage form is a soluble concentrate, and the excipients are prepared from the following raw materials by weight percentage: 1% benzo[a]pyrrolidone, 2% isopsoralen, 30% propylene glycol, 1% N-methylpyrrolidone, 1% alkyl glycoside O814, 7% Tween-80, 10% styrene-phenol polyoxyethylene polyoxypropylene ether, and 48% deionized water. First, isopsoralen and benzo[a]pyrrolidone are dissolved in N-methylpyrrolidone. Then, propylene glycol, alkyl glycoside, Tween-80, and styrene-phenol polyoxyethylene polyoxypropylene ether are added sequentially. After stirring evenly, deionized water is added while stirring until a homogeneous liquid is formed, thus obtaining the soluble concentrate.

6. The method for preparing a mixed formulation of isopsoralen and benzylpropionate for controlling plant bacterial diseases as described in claim 4, characterized in that, The target dosage form is a microemulsion. The excipients are prepared from raw materials containing the following weight percentages: 0.2% benzo[a]pyrene, 0.1% isopsoralen, 13% castor oil polyoxyethylene ether, 1% calcium dodecylbenzenesulfonate, 35% glycerol, 2% polyethylene glycol, and 48.7% deionized water. First, isopsoralen and benzo[a]pyrene are dissolved in glycerol to obtain an oil phase. Then, castor oil polyoxyethylene ether, calcium dodecylbenzenesulfonate, polyethylene glycol, and deionized water are mixed and stirred evenly to obtain an aqueous phase. The aqueous phase is then slowly added to the oil phase while stirring. Finally, the mixture is stirred until a homogeneous and transparent liquid is obtained, which is the microemulsion.

7. The preparation method of the mixed formulation of isopsoralen and benzylpropionate for controlling plant bacterial diseases as described in claim 4, characterized in that, The target dosage form is a microcapsule formulation. The excipients are prepared from raw materials containing the following weight percentages: 6% benzo[a]pyrethrum, 1.5% isopsoralen, 9% isocyanate, 5% Span-80, 6% fatty alcohol polyoxyethylene ether, 9% sodium lignosulfonate, 1.5% ethylenediamine, 2% ethylene glycol, and 60% deionized water. First, isopsoralen and benzo[a]pyrethrum are fully dissolved in the isocyanate monomer, then Span-80 is added and stirred until homogeneous to prepare the oil phase. Separately, deionized water is taken, and fatty alcohol polyoxyethylene ether, sodium lignosulfonate, and ethylene glycol are added sequentially, stirring continuously until completely dissolved and homogeneous. The pH of the system is adjusted to 7-8 to obtain the aqueous phase. Under high-speed stirring, the oil phase is slowly added dropwise to the aqueous phase, while simultaneously adding an aqueous solution of ethylenediamine dropwise, to obtain the isopsoralen•benzo[a]pyrethrum microcapsule formulation.

8. The method for preparing a mixed formulation of isopsoralen and benzyl propiconazole for controlling plant bacterial diseases as described in claim 7, characterized in that, Under stirring conditions, the oil phase was slowly added dropwise to the aqueous phase, followed by high-speed shear emulsification at 10,000 rpm for 20 min to prepare a stable O / W emulsion. Then, under stirring conditions, an aqueous solution of ethylenediamine was slowly added dropwise to the above O / W emulsion. After stirring at a constant temperature for 50 min, a small amount of impurities were removed by filtration to obtain the isopsoralen·benzylpropionate microcapsule formulation.

9. The preparation method of the mixed formulation of isopsoralen and benzyl propiconazole for controlling plant bacterial diseases as described in claim 4, characterized in that, The isopsoralen is prepared by the following steps: S10. First, mix choline chloride and ethylene glycol in a 1:2 molar ratio and stir at 60°C until a homogeneous and transparent liquid is formed to obtain a eutectic solvent system. S20. After crushing the Psoralea corylifolia seeds to 60 mesh using a high-speed seed crusher, add a DES-ethanol mixture with a volume ratio of 7:3, wherein the material-to-liquid ratio is 1:20 g / mL. S30. After ultrasonic-assisted extraction, centrifugation, and filtration of the supernatant, the above solution is extracted with 3 times the volume of ethyl acetate. The ethyl acetate layer is collected and concentrated under reduced pressure to obtain the extract. S40. Dissolve the above extract in methanol at a mass-volume ratio of 1:25 g / mL, and analyze the components of the extract using analytical high performance liquid chromatography to confirm the retention time of isopsoralen. S50. Use a semi-preparative high-performance liquid chromatograph to separate and purify the components in the extract; S60. The isopsoralen fraction was manually collected according to the retention time window determined by the analytical chromatogram. The collected liquids were combined and concentrated under reduced pressure at 40°C to remove the solvent, so as to obtain pure isopsoralen.